2025
SJR Q2
JCR Q2 · 3,4
402 matched articles
SCIE
Journal detail
Journal of Pharmaceutical and Biomedical Analysis
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
073170851873264X
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,604
- Quartile Q2
- H-Index 160
- Cites/doc 3,66
- Docs (3y) 1.706
- Cites (3y) 6.442
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,4
- 5Y JIF 3,3
- JCI 0,82
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Analytical Chemistry Q2
- Clinical Biochemistry Q3
- Drug Discovery Q2
- Pharmaceutical Science Q2
- Spectroscopy Q2
Areas
- Biochemistry, Genetics and Molecular Biology
- Chemistry
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Chemistry, Analytical | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,604 | 3,4 | 3,3 | 0,82 | Q2 | 160 |
| 2024 | Q2 | Q2 | 0,628 | 3,1 | 3,1 | 0,86 | Q2 | 154 |
| 2023 | Q2 | Q2 | 0,584 | 3,1 | 3,1 | 0,88 | Q1 | 154 |
| 2022 | Q2 | Q2 | 0,608 | 3,4 | 3,3 | 0,91 | Q1 | 154 |
| 2021 | Q2 | Q2 | 0,657 | 3,6 | 3,6 | 0,94 | Q1 | 154 |
| 2020 | Q1 | Q2 | 0,777 | 3,9 | 3,6 | 0,98 | Q1 | 154 |
| 2019 | Q1 | Q2 | 0,795 | 3,2 | 3,1 | 1 | Q1 | 154 |
| 2018 | — | Q2 | — | 3 | 3,1 | 1,01 | Q1 | — |
| 2017 | Q1 | Q2 | 0,919 | 2,8 | 2,9 | 1,06 | Q1 | 154 |
| 2016 | Q1 | Q1 | 0,92 | 3,3 | 3 | — | — | 154 |
| 2015 | Q1 | Q1 | 1,052 | 3,2 | 2,9 | — | — | 154 |
| 2014 | Q1 | Q1 | 1,056 | 3 | 2,9 | — | — | 154 |
| 2013 | Q1 | Q2 | 1,235 | 2,8 | 2,9 | — | — | 154 |
| 2012 | Q1 | Q2 | 1,198 | 2,9 | 2,9 | — | — | 154 |
| 2011 | Q1 | Q2 | 1,191 | 3 | 3 | — | — | 154 |
| 2010 | Q1 | Q2 | 1,118 | 2,7 | 2,7 | — | — | 154 |
| 2009 | — | Q2 | — | 2,5 | 2,5 | — | — | — |
| 2008 | — | Q2 | — | 2,6 | 2,5 | — | — | — |
| 2007 | — | Q2 | — | 2,8 | 2,5 | — | — | — |
| 2006 | — | Q2 | — | 2 | — | — | — | — |
| 2005 | — | Q2 | — | 1,9 | — | — | — | — |
| 2004 | — | Q2 | — | 1,5 | — | — | — | — |
| 2003 | — | Q2 | — | 1,4 | — | — | — | — |
| 2002 | — | Q2 | — | 1,4 | — | — | — | — |
| 2001 | — | Q3 | — | 1,2 | — | — | — | — |
| 2000 | — | Q3 | — | 1 | — | — | — | — |
| 1999 | — | Q3 | — | 1 | — | — | — | — |
| 1998 | — | Q3 | — | 0,9 | — | — | — | — |
| 1997 | — | Q3 | — | 1 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 48/110 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 143/356 |
| 2024 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q2 | 45/111 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 134/352 |
| 2023 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 37/106 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 126/354 |
| 2022 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 29/86 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 125/278 |
| 2021 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 32/87 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 143/279 |
| 2020 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 24/87 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 113/276 |
| 2019 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 26/86 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 100/271 |
| 2018 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 24/84 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 105/267 |
| 2017 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | Q1 | 23/81 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q1 | 105/261 |
| 2016 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 18/76 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/257 |
| 2015 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 14/75 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 70/255 |
| 2014 | CHEMISTRY, ANALYTICAL | SCIE | Q1 | — | 16/74 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 81/255 |
| 2013 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 22/76 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/256 |
| 2012 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 19/75 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 78/261 |
| 2011 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 20/73 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 80/261 |
| 2010 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 20/73 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 91/252 |
| 2009 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 23/70 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 111/237 |
| 2008 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 18/70 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 86/219 |
| 2007 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 19/70 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 67/205 |
| 2006 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 24/68 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 97/199 |
| 2005 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 21/70 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 97/193 |
| 2004 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 28/70 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/187 |
| 2003 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 30/67 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/185 |
| 2002 | CHEMISTRY, ANALYTICAL | SCIE | Q2 | — | 30/68 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 105/188 |
| 2001 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 35/68 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/186 |
| 2000 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 41/65 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 116/181 |
| 1999 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 38/66 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 102/175 |
| 1998 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 37/65 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 102/178 |
| 1997 | CHEMISTRY, ANALYTICAL | SCIE | Q3 | — | 35/61 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 91/157 |